Asset Details
Do you wish to reserve the book?
A novel variant of telomerase reverse transcriptase (TERT) associated with risk of glioma in a Korean population
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A novel variant of telomerase reverse transcriptase (TERT) associated with risk of glioma in a Korean population
Do you wish to request the book?
A novel variant of telomerase reverse transcriptase (TERT) associated with risk of glioma in a Korean population
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A novel variant of telomerase reverse transcriptase (TERT) associated with risk of glioma in a Korean population
2025
Overview
Among central nervous system (CNS) tumors, gliomas are the most prevalent type of tumor. Single nucleotide polymorphisms (SNPs) in
telomerase reverse transcriptase
(
TERT
) gene have been identified as risk loci for gliomas by previous genome-wide association studies (GWAS). We examined association between
TERT
variants and glioma risk in a Korean population. For a case-control study, a total of 32
TERT
SNPs from 317 patients with glioma and 480 population-based controls were genotyped. Logistic regression was used for statistical analysis of the link between
TERT
SNPs and risk of glioma. In this study, eight
TERT
variants, including four glioma-associated variants reported in previous studies, showed significant association with the risk of glioma. Conditional and stepwise analyses were conducted to validate independent associations in the group of the eight variants. Both analyses identified an intronic variant (
rs56345976
) as the causal variant among the eight variants. Glioma subgroup analyses indicate that
rs56345976
variant is associated with the risk of WHO grade 4, glioblastoma,
isocitrate dehydrogenase
(IDH) wild-type, and 1p/19q non-codeletion glioma. This study presents a profound comprehension of the relationship between
TERT
variants and the risk of glioma. Further studies of this variant are required to investigate its effect on glioma susceptibility.
Publisher
Nature Publishing Group UK,Nature Portfolio
